226 related articles for article (PubMed ID: 22194364)
1. Biologic imaging of head and neck cancer: the present and the future.
Srinivasan A; Mohan S; Mukherji SK
AJNR Am J Neuroradiol; 2012 Apr; 33(4):586-94. PubMed ID: 22194364
[TBL] [Abstract][Full Text] [Related]
2. Functional imaging for radiation treatment planning, response assessment, and adaptive therapy in head and neck cancer.
Bhatnagar P; Subesinghe M; Patel C; Prestwich R; Scarsbrook AF
Radiographics; 2013; 33(7):1909-29. PubMed ID: 24224586
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Head and Neck Tumors with Functional MR Imaging.
Jansen JFA; Parra C; Lu Y; Shukla-Dave A
Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):123-133. PubMed ID: 26613878
[TBL] [Abstract][Full Text] [Related]
4. [New opportunities, MRI biomarkers in the evaluation of head and neck cancer].
Gődény M; Léránt G
Magy Onkol; 2014 Dec; 58(4):269-80. PubMed ID: 25517445
[TBL] [Abstract][Full Text] [Related]
5. [Molecular imaging of head and neck cancers : Perspectives of PET/MRI].
Stumpp P; Purz S; Sabri O; Kahn T
Radiologe; 2016 Jul; 56(7):588-96. PubMed ID: 27306200
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma.
Hoefling NL; McHugh JB; Light E; Kumar B; Walline H; Prince M; Bradford C; Carey TE; Mukherji SK
AJNR Am J Neuroradiol; 2013 May; 34(5):1062-6, S1-2. PubMed ID: 23370473
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation.
Covello M; Cavaliere C; Aiello M; Cianelli MS; Mesolella M; Iorio B; Rossi A; Nicolai E
Eur J Radiol; 2015 Jul; 84(7):1269-76. PubMed ID: 25958189
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
Grönroos TJ; Lehtiö K; Söderström KO; Kronqvist P; Laine J; Eskola O; Viljanen T; Grénman R; Solin O; Minn H
BMC Cancer; 2014 Nov; 14():876. PubMed ID: 25421331
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
10. Advanced neuroimaging in traumatic brain injury: an overview.
Smith LGF; Milliron E; Ho ML; Hu HH; Rusin J; Leonard J; Sribnick EA
Neurosurg Focus; 2019 Dec; 47(6):E17. PubMed ID: 32364704
[TBL] [Abstract][Full Text] [Related]
11. Imaging inflammation and neovascularization in atherosclerosis: clinical and translational molecular and structural imaging targets.
Osborn EA; Jaffer FA
Curr Opin Cardiol; 2015 Nov; 30(6):671-80. PubMed ID: 26398413
[TBL] [Abstract][Full Text] [Related]
12. PET/MR in cancers of the head and neck.
Queiroz MA; Huellner MW
Semin Nucl Med; 2015 May; 45(3):248-65. PubMed ID: 25841279
[TBL] [Abstract][Full Text] [Related]
13. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
[TBL] [Abstract][Full Text] [Related]
14. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
Li LF; Zhou SH; Zhao K; Wang SQ; Wu QL; Fan J; Cheng KJ; Ling L
Cancer Biother Radiopharm; 2008 Dec; 23(6):701-14. PubMed ID: 19317609
[TBL] [Abstract][Full Text] [Related]
16. Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.
Benz MR; Vargas HA; Sala E
Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):1-10. PubMed ID: 26613872
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
[TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
19. Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.
Evangelista L; Cervino AR; Chondrogiannis S; Marzola MC; Maffione AM; Colletti PM; Muzzio PC; Rubello D
Nucl Med Commun; 2014 Feb; 35(2):123-34. PubMed ID: 24220055
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive metabolic imaging of brain tumours in the era of precision medicine.
Kim MM; Parolia A; Dunphy MP; Venneti S
Nat Rev Clin Oncol; 2016 Dec; 13(12):725-739. PubMed ID: 27430748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
